Yuyu Pharm Appoints Hyunki Ryu as Head of Development
Extensive Experience in Development Planning and Business Development at Multiple Pharmaceutical Companies
Yuyu Pharm announced on April 1 that it has appointed Hyunki Ryu, who has built expertise in development planning and business development (BD) at major domestic pharmaceutical companies, as Head of Development (Executive Director).
Ryu graduated from the College of Pharmacy at Sungkyunkwan University and its graduate school. He previously worked at Kwangdong Pharmaceutical, Kyungnam Pharm, and Korea Pharmbio, and served as Head of Development at Hanwha Pharmaceutical.
He has experience in various development work, including pharmaceuticals such as OTC and ETC drugs, as well as food and beverages. Ryu has planned differentiated new drug development such as improved drugs, and has experience working with overseas partners in licensing and business development. While at Kwangdong Pharmaceutical, he led vaccine co-promotion projects with multinational pharmaceutical companies, laying the foundation for new businesses. At Hanwha Pharmaceutical, he spearheaded the establishment of a high-value-added improved drug pipeline.
Hot Picks Today
"Two Spend 500,000 Won in a Flash, Yet Wait Two Hours?" ... 'Dreamland' Shunned by Kids and Foreign Tourists
- The Era of Getting 200 Million Won After 30 Years Is Over... A Japanese Bank's "Perpetual Department Head" Who Just Clocked In Cries Out
- Spain Hit by Its Worst Tragedy... Lee Kangin, Moreno and Real Madrid Join Soccer World in Mourning
- They Said, “Make It Your Home for Life” - Then Suddenly Kicked 200 Passengers Off... What Happened to the Around-the-World Cruise?
- "130 Rice Bowls Sold Out in a Day"... 'Unfiltered Face' Adds 8 Million Won to Night Market Sales: China's Bungeunwoo
Ryu stated, "Building on Yuyu Pharm's 85 years of trust and excellent manufacturing infrastructure, I will dedicate myself to developing next-generation improved drugs and specialized formulations centered on profitability, continuing the legacy of Tanamin, Maxmavill, and Euclid. I also aim to establish Yuyu Pharm's unique technological barriers, driving the company's sustainable growth."
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.